British drugmaker GSK raises USD 1.1 billion from Haleon stake sale Ruchika Sharma7 Oct 2023 1:30 PM ISTPfizer, which holds a 32% stake in Haleon, said in May it plans to cut its ownership in a "slow and methodical" manner within months.
Wendy Becker to join GSK board as Non-Executive Director Ruchika Sharma28 Sept 2023 1:30 PM ISTLondon: GSK plc has announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with effect from 1 October 2023.On...
Scynexis to recall GSK partnered antifungal pill over cross contamination risk Ruchika Sharma26 Sept 2023 4:30 PM ISTScynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
GSK gets USFDA nod for bone marrow cancer therapy Ojjaara Ruchika Sharma16 Sept 2023 11:54 AM ISTOjjaara is a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor.
JnJ, P&G, Walgreens accused in lawsuits over cold medicine decongestant Ruchika Sharma15 Sept 2023 2:30 PM ISTJohnson & Johnson, Procter & Gamble and Walgreens are among several companies accused in lawsuits of deceiving consumers about cold...
GSK regulatory submission for myelofibrosis medicine momelotinib accepted for review by Japanese regulator Ruchika Sharma12 Sept 2023 11:29 AM ISTLondon: GSK plc has announced that the Ministry of Health, Labour and Welfare (MHLW), Japan, has accepted for review a new drug application (NDA) for...
SC relief to GSK, junks plea claiming deficiency of service by Pharma company on account of alleged vaccine side effects Ruchika Sharma11 Sept 2023 3:14 PM ISTThe apex court said that non-mentioning of myositis as an adverse reaction in the literature accompanying the injection or on the vial, did not amount...
GSK regulatory submission accepted for review by Japanese regulator for Nucala use in adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2023 12:45 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug...
Counterfeit medicines worth Rs 2 crore of Augmentin, Pan-D, Urimax-D and others seized from Kolkata warehouse Ruchika Sharma4 Aug 2023 2:30 PM IST"During the raid, counterfeit medicines, worth about Rs 2 crore of leading manufacturers such as Sun Pharmaceutical, Alkem, Cipla, Glenmark, GSK,...
Pfizer sued by GSK for patent infringement over RSV vaccine Ruchika Sharma3 Aug 2023 12:30 PM ISTA GSK spokesperson said in a statement that intellectual property protections are the "foundation of research-based companies' ability to drive...
GSK gets USFDA nod for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer Ruchika Sharma1 Aug 2023 11:30 AM ISTJemperli is already approved in the US as monotherapy in adult patients with dMMR recurrent or advanced endometrial cancer that has progressed on or...
